Registration is closed for 2008

Registration is closed for 2007

Wednesday, August 15, 2007

Registration and Check-in
Brook Lodge, Radisson and Yarrow

Welcome Dinner & Reception
Reception 5:30 p.m., Dinner 6:30 p.m.

Thursday, August 16, 2007

Embryonic Stem Cells and Nuclear Transfer: Challenges and Opportunities
Michael West, PhD
President and CSO
Advanced Cell Technology

Endogenous and Exogenous Stem Cells for Cardiac Repair
Michael Laflamme, MD, PhD
Assistant Professor
Department of Pathology
Center for Cardiovascular Biology and Regenerative Medicine
University of Washington

The Microvasculature as a Therapeutic Target in Ischemic Disease
Joern Tongers , MD
Scientist

Promise and Scientific Challenges of Developing a Stem Cell Based Therapy for Diabetes
Jon S. Odorico, MD, FACS
Associate Professor of Surgery
Division of Transplantation/Department of Surgery
University of Wisconsin-Madison

A Cell-Based Therapy for Diabetes: Embryonic, Fetal, or Adult Cells?
Alberto Hayek, MD
Director, Islet Research Laboratory
The Whittier Institute for Diabetes
University of California, San Francisco

Preclinical Challenges for a Stem Cell Product Moving Towards Market Approval
Robert E. Newman, Jr., PhD
Scientist
Osiris Therapeutics, Inc.

Human Embryonic Stem Cells as a Model for Oncogenesis and Novel Anti-Tumor Therapies
Dan Kaufman, MD, PhD
Stem Cell Institute and Department of Medicine
Division of Hematology, Oncology, and Transplantation
University of Minnesota
Translational Research Facility

Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors for the Treatment of Spinal Cord Injury: Preclinical Efficacy and Safety
Catherine Priest, PhD
Group Leader
Neurobiology Research in Regenerative Medicine
Geron Corporation

From Embryonic Stem Cells to Neural Stem Cells to Differentiated Cells
Mahendra Rao, PhD
Vice President of Research, Stem Cells, and Regenerative Medicine

Neuronal Specification from Human Embryonic Stem Cells: Model for Developing Therapeutics for Neurological Diseases
Su-Chun Zhang, MD, PhD
Assistant Professor
University of Wisconsin-Madison
School of Medicine and Public Health
Department of Anatomy

Preclinical Studies of Glial Restricted Precursors and Motor Neurons in Rodent Models of Human Neurological Diseases
Douglas Kerr, MD, PhD
Assistant Professor
Neurology and MNI
Director
Johns Hopkins Transverse Myelitis Center
Johns Hopkins Hospital

Friday, August 17, 2007

Novel Therapeutic Approaches for Neurodegenerative Diseases
Nilabh Chaudhary, PhD
CEO
NeoCytex Biopharma, Inc.

MR Imaging and Tracking of Cellular Therapeutics
Jeff Bulte, PhD
Director, Cellular Imaging Section, Institue for Cell Engineering
Johns Hopkins University School of Medicine

Key Considerations Regarding Preclinical Development of Cell-Based Therapies: Facilitating Clinical Trials
Joy Cavagnaro, PhD
President
Access BIO, LC

US Regulations for Preclinical and Phase I Manufacturing
Linda Lemieux, ALM
Director, QA/QC
Advanced Cell Technology

Contact us at +1.269.668.3336, ext. 4202 or Summit@mpiresearch.com.for more information. Check back frequently for summit updates!